Security key
N71542109
ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR)
CUSIP: N71542109
Q1 2023 13F Holders as of 31 Mar 2023
- Security type / class
- Equity / Ordinary Shares, nominal value Euro 0.04 per share
- Total 13F shares
- 22,322,571
- Total 13F value
- $47,544,921
- Share change
- +5,644,972
- Put/Call ratio
- 84%
- SEC-reported price per share
- $2.13
- Number of holders
- 54
- Value change
- +$11,107,713
- Number of buys
- 34
- Number of sells
- 11
- Shares outstanding
- 141,139,908
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2023
Institutions
54
Top holders
10
PRQR full security history
Ownership snapshot
Full 13F holder table
ProQR Therapeutics N.V. SEC filings
ProQR Therapeutics N.V. company facts
Broader feeds
Ownership snapshot
Top reported holders of PRQR - ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Privium Fund Management B.V.
Disclosed value leader
Privium Fund Management B.V.
Comparable rows
15/15
Latest evidence
31 Dec 2022
13F
Lead comparable stake: 3.8%
Showing 1-6 of 15 holder rows.
Quick read
Privium Fund Management B.V. leads the comparable SEC ownership view at 3.8%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Privium Fund Management B.V.'s linked filing trail.
Comparable ownership
Top 5
Privium Fund Management B.V.
3.8%
ADAGE CAPITAL PARTNERS GP, L.L.C.
2.6%
M28 Capital Management LP
1.4%
Opaleye Management Inc.
1%
MACQUARIE GROUP LTD
0.44%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Privium Fund Management B.V. |
13F
Company
|
3.8%
|
$18,010,783
5,344,446 shares
|
— | 31 Dec 2022 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
Company
|
2.6%
|
$13,414,228
3,625,467 shares
|
— | 31 Dec 2022 |
| M28 Capital Management LP |
13F
Company
|
1.4%
|
$7,069,220
1,910,600 shares
|
— | 31 Dec 2022 |
| Opaleye Management Inc. |
13F
Company
|
1%
|
$5,402,000
1,460,000 shares
|
— | 31 Dec 2022 |
| MACQUARIE GROUP LTD |
13F
Company
|
0.44%
|
$2,294,000
620,000 shares
|
— | 31 Dec 2022 |
| Ikarian Capital, LLC |
13F
Company
|
0.3%
|
$1,563,713
422,625 shares
|
— | 31 Dec 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
54
Shares
22,322,571
Rows available
54
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2023 vs Q1 2023 Across Filers
Q1 2023 holders
54
Q1 2023 holders
54
Holder diff
0
| Investor | Q1 2023 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q1 2023 value | Q1 2023 value | Value change | Value Chg % |
|---|